Analysts are optimistic about Medtronic (MDT) after the Centers for Medicare and Medicaid Services (CMS) proposed to cover ...

On Thursday, the US Centers for Medicare & Medicaid Services (CMS) issued its proposal for covering radiofrequency- or ...

CMS proposed Medicare coverage for Medtronic's renal denervation therapy for high blood pressure, signaling a key step toward ...

The patented method uses genetic markers and a weighted algorithm to assess the responsiveness to renal denervation.

Medtronic and Recor Medical both issued statements supporting new Medicare coverage for their respective renal denervation ...

Medtronic and Recor Medical stand to benefit from national Medicare coverage for their new device-based treatments for patients with uncontrolled high blood pressure.

About the Paradise Ultrasound Renal Denervation System The Paradise uRDN system is a first-of-its-kind ultrasound-based RDN ...

Recall that Medtronic acquired the renal denervation technology from Mountain View, California-based Ardian back in 2010 for $800 million plus milestone payments. Ardian was developing a catheter ...

Renal denervation could be very effective and helpful for those patients," says Fisher. "But there are 110 to 120 million US patients with hypertension, and close to 75% are not reaching goal.

The United States Food and Drug Administration, in 2023, approved renal denervation—a catheter-based procedure that ablates the renal sympathetic nerves—as an adjunctive treatment for patients ...

In recent years, catheter-based radiofrequency denervation of the renal arteries has emerged as a potential treatment for resistant hypertension and is already in clinical use in more than 80 ...